Re2O Skin Boosterin Seoul With Human Dermal Matrix

Re2O belongs to the group of injectables aimed at skin quality: how dense, smooth and well hydrated the skin looks and feels. It is placed in the dermis, the layer under the surface that thins with age and sun exposure, and the matrix is meant to act as a framework that the skin's own repair cells can work on. That makes it a fit for texture and fine crepiness across the face, where a volumizing filler would sit heavy.

It is a poor match for structural problems. Deep folds come from lost volume, and loose skin along the jaw comes from laxity, so those point to fillers, collagen stimulators or lifting. Because Re2O is derived from donated human tissue, it is also worth deciding before the consultation whether you are comfortable with that origin; other boosters on the menu use different ingredients, listed in the comparison table below.

Elravie Re2O comes from L&C BIO, a Korean company. The starting material is donated human dermis that has been decellularized, meaning the cells are removed so that what remains is the extracellular matrix: collagen, elastin and the other structural proteins that hold the dermis together. That matrix is then broken into fine particles that can pass through a needle or cannula. Once injected, the particles are intended to work as a scaffold and a signal, giving fibroblasts, the skin's collagen-making cells, a framework to grow into.

The clinical research uses dermal matrix products in general, and the trials below do not name Re2O, so they describe the material class. In a split-face, double-blind trial, a particulated human acellular dermal matrix booster improved skin density, elasticity, wrinkles and hydration more than a hyaluronic acid control, with no serious adverse events (Lee, 2026). In a multicenter randomized trial for nasolabial folds, a micronized dermal matrix injection was non-inferior to a collagen filler using less volume, though early swelling and pain were slightly more common and cleared within a week (Zhang, 2025).

The clinic's list has two Re2O lines, each charged per session: Re2O at ₩1,200,000 and Re2O Fine at ₩800,000. Neither figure includes tax; Korea's 10% VAT is added when you pay. The starting plan is three sessions, so a first course is three session fees of whichever line your plan uses.

The clinic's materials do not set out how Re2O Fine differs from standard Re2O. When you request a quote, ask which line is planned for your skin and for the course total to be written out.

Any injection into facial skin carries short-term reactions, and a product built from human tissue adds the question of how your body responds to it. A review of skin-rejuvenating mesotherapy, the broad family of injections into the dermis for skin quality, found no clinically valuable new evidence over a decade and advised against routine use until conclusive data arrive (Atiyeh, 2021).

• Swelling, redness and raised bumps for one to three days.
• Bruising or needle marks lasting three to seven days.
• Small lumps or uneven texture if the material gathers in one spot.
• Infection at needle or cannula entry points.
• A reaction to the injected material, such as prolonged redness or a firm nodule.
• With any facial injection, a rare blockage of a blood vessel; pain that spreads or skin that turns pale or dusky needs urgent attention.

The trials on dermal matrix boosters are short and small, and none tested Re2O by name, so the evidence supports trying the treatment with modest expectations.